[
  {
    "date": "524804  |  \n                                                                            Board Meeting Intimation for Intimation Of Board Meeting To Be Held On November 5, 2025 For Consideration Unaudited Financial Results For The Second Quarter & Half Year Ended On September 30, 2025.",
    "subject": "Board Meeting",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/ff84eebd-d893-4114-ae40-a2e4c42a0f45.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Announcement under Regulation 30 (LODR)-Acquisition",
    "subject": "Company Update",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/d277e961-c6ba-413b-867d-2849c0b8b4b5.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Announcement under Regulation 30 (LODR)-Newspaper Publication",
    "subject": "Company Update",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/6df3419c-2fde-42dd-8301-6bfb061006e6.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
    "subject": "Company Update",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/c6a4f985-cf3d-4a71-93c7-2a4ad925185f.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Announcement under Regulation 30 (LODR)-Change in Management",
    "subject": "Company Update",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/12661919-e970-4ca4-8590-d83c8d5e8418.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Announcement under Regulation 30 (LODR)-Updates on Acquisition",
    "subject": "Company Update",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/39be82e1-d755-4880-b5c6-5ee205d9b2cc.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Closure of Trading Window",
    "subject": "Insider Trading / SAST",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/83c8397f-3826-4295-8177-d5c8081594dc.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Fire Accident At Unit-IV Of APL Healthcare Limited, A Wholly Owned Subsidiary Of The Company",
    "subject": "Company Update",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/2163926a-c343-4482-8653-13ddde9f2759.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Curateq Biologics Announces Successful Completion Of Phase 3 Clinical Study For Denosumab Biosimilar.",
    "subject": "Company Update",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/9e0f851f-c59c-40e6-80ac-f25fd0ab4cfa.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
    "subject": "Company Update",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/a3a18ea2-0cca-46d0-9fe2-404106d13a14.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Clarification On Significant Volume Movement In Company'S Shares",
    "subject": "Company Update",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/5787cc75-3033-4226-ae11-dce6bd23ce64.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Clarification sought from Aurobindo Pharma Ltd",
    "subject": "Company Update",
    "attachment": null
  },
  {
    "date": "524804  |  \n                                                                            Shareholder Meeting / Postal Ballot-Scrutinizer''s Report",
    "subject": "AGM/EGM",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/1f0db7a9-ffa6-4ff8-b8c0-1a9e7f4a1da3.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Shareholder Meeting / Postal Ballot-Outcome of AGM",
    "subject": "AGM/EGM",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/d88fe195-bfad-4a67-b662-e460f05153bc.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Completion Of US FDA Inspection At Unit-XII Of Aurobindo Pharma Limited",
    "subject": "Company Update",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/c0b6111a-df67-456c-be19-06c427e10fcf.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Completion Of US FDA Inspection At Unit-I Of Apitoria Pharma Private Limited, A Wholly Owned Subsidiary Of The Company",
    "subject": "Company Update",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/a6e05875-fc08-4dea-a591-1fabbaa45af1.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
    "subject": "Company Update",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/454b4890-d646-4b91-b0d7-65f6512a1f4c.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Curateq Biologics S.R.O, A Wholly Owned Step-Down Subsidiary Of The Company Receives Approval For Biosimilar Dazublys From UK'S MHRA",
    "subject": "Company Update",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/b75229da-a670-4ac6-a0af-05437f07407b.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Rumour verification - Regulation 30(11)",
    "subject": "Others",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/5a40d897-0b16-4a33-afa6-23e41535fdfe.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements)\nRegulations, 2015",
    "subject": "Company Update",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/060a66e9-87bd-46b3-bcd5-184f039e6c0c.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Business Responsibility and Sustainability Reporting (BRSR)",
    "subject": "Others",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/fe003309-4ba7-48dd-9879-f77c9134d49a.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Notice Of 38Th Annual General Meeting Scheduled To Be Held On September 10, 2025",
    "subject": "AGM/EGM",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/52e9edcf-3ac0-4316-a264-18489371cf59.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Reg. 34 (1) Annual Report.",
    "subject": "Others",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/0e3a5b88-6f3b-4a5d-8d07-7186fd4b1f25.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Intimation Of 38Th Annual General Meeting Of Aurobindo Pharma Limited.",
    "subject": "AGM/EGM",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/e0050817-4f4a-4da3-b93a-51fc03212d70.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
    "subject": "Company Update",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/cba3da3b-6c58-4ea1-99f1-5853086d9a8a.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Announcement under Regulation 30 (LODR)-Press Release / Media Release",
    "subject": "Company Update",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/e6f3a9ef-5218-4f6a-8003-c21941c6a8d9.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Announcement under Regulation 30 (LODR)-Investor Presentation",
    "subject": "Company Update",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/8315ee0f-ddb9-4da4-808f-ca32938618e5.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Intimation Of Record Date For Payment Of Interim Dividend For The FY 2025-26",
    "subject": "Corp. Action",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/b872e20f-f181-4d87-b19a-69674fd289fe.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Corporate Action-Board approves Dividend",
    "subject": "Corp. Action",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/3a104934-b55d-4e9b-91ab-17bf663a12f9.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Board Meeting Outcome for Outcome Of The Board Meeting Held On August 4, 2025",
    "subject": "Board Meeting",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/dd3e24d6-efee-4b4f-a7ae-6eb284961b63.pdf"
  },
  {
    "date": "524804  |  \n                                                                            Clarification On News Item Appearing In 'Media/Publication",
    "subject": "Company Update",
    "attachment": "https://www.bseindia.com/xml-data/corpfiling/AttachHis/512bb3c4-69ac-49d0-a7d8-c37f86351717.pdf"
  }
]